
Tamoxifen hormone therapy has played a central role in managing hormone receptor–positive breast cancer for decades, both as treatment and as a way to lower future risk. Tamoxifen breast cancer therapy is part of a class of medicines called SERMs (selective estrogen receptor modulators), which act as hormone blockers in breast tissue while having different effects in other parts of the body.
By targeting how estrogen interacts with breast cells, tamoxifen has become one of the most widely used breast cancer drugs in both treatment and prevention settings.